Neuropathology of non-motor features of Parkinson disease (Q37677151)

21 August 2017

1 reference

title

Neuropathology of non-motor features of Parkinson disease (English)

1 reference

21 August 2017

1 reference

1

1 reference

21 August 2017

Carolyn Orr

3

0 references

J Eric Ahlskog

10

object named as

J Eric Ahlskog

1 reference

21 August 2017

Hiroshige Fujishiro

2

1 reference

21 August 2017

Anthony DelleDonne

4

1 reference

21 August 2017

Keith A Josephs

5

1 reference

21 August 2017

Roberta Frigerio

6

1 reference

21 August 2017

Melinda Burnett

7

1 reference

21 August 2017

Joseph E Parisi

8

1 reference

21 August 2017

Kevin J Klos

9

1 reference

21 August 2017

1 December 2009

1 reference

Parkinsonism and Related Disorders

21 August 2017

1 reference

21 August 2017

15 Suppl 3

1 reference

21 August 2017

S1-5

1 reference

The Parkinson's complex: parkinsonism is just the tip of the iceberg

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Regional distribution of proteinase K-resistant alpha-synuclein correlates with Lewy body disease stage.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Multiple-system atrophy: a new alpha-synuclein disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Glial reactions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Autonomic dysfunction in men with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Ultrastructure of Lewy bodies in the stellate ganglion

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Pure autonomic failure in association with human alpha-synucleinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Bowel movement frequency in late-life and incidental Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Where does parkinson disease pathology begin in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Lewy body pathology involves cutaneous nerves.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Pathological lesions in colonic biopsies during Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Olfaction and Parkinson's syndromes: its role in differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

The nature and course of olfactory deficits in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Biopsies of olfactory epithelium in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Risk factors for depression in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Dementia and survival in Parkinson disease: a 12-year population study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Risk of dementia in Parkinson's disease: a community-based, prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

The progression of pathology in longitudinally followed patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Clinical diagnostic criteria for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Basal forebrain neurons in the dementia of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970769-2

7 January 2021

10.1016/S1353-8020(09)70769-2

Identifiers

DOI

1 reference

21 August 2017

1 reference